MAR
60
7
ACN
56
13
COST
56
3
NAVI
55
-2
FLS
56
-3
RRC
56
4
PPL
65
6
HSY
40
2
AN
50
-5
FAST
46
-3
IR
72
-5
TSN
31
-4
MTCH
44
-4
RF
51
-2
LYB
46
-4
LMT
47
7
R
66
-4
EQR
54
-2
BWA
45
-4
AME
57
-2
MAR
60
7
ACN
56
13
COST
56
3
NAVI
55
-2
FLS
56
-3
RRC
56
4
PPL
65
6
HSY
40
2
AN
50
-5
FAST
46
-3
IR
72
-5
TSN
31
-4
MTCH
44
-4
RF
51
-2
LYB
46
-4
LMT
47
7
R
66
-4
EQR
54
-2
BWA
45
-4
AME
57
-2
Financhill
Back

Vicat SA Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
42

SDCVF
Vicat SA

Last Price:
32.63
Seasonality Move:
27.68%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
42
Vicat SA (SDCVF) is a Sell

Is Vicat SA a Buy, Sell or Hold?

  • The current Vicat SA [SDCVF] share price is $32.63. The Score for SDCVF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SDCVF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SDCVF Stock Price Chart

What is Vicat SA's stock price today?

  • The Vicat SA share price today is $32.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SDCVF is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SDCVF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 2.28 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.63 - 32.63) Sell
Bollinger Bands (100): (33.51 - 38.69) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SDCVF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.63 Sell
20-day SMA: 32.63 Sell
50-day SMA: 33.99 Sell
200-day SMA: 35.96 Sell
8-day EMA: 32.63 Sell
20-day EMA: 32.83 Sell
50-day EMA: 33.95 Sell
200-day EMA: 34.79 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Vicat SA Earnings Growth & SDCVF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Vicat SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):